This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San Diego

Chang Liu, PhD
Professor and Chancellor's Fellow, Biomedical Engineering at UC Irvine
Speaker

Profile

Chang Liu is Professor and Chancellor's Fellow of Biomedical Engineering, Chemistry, and Molecular Biology & Biochemistry, the Director of the Center for Synthetic Biology, and the Director of the Engineering + Health Institute at UC Irvine. After graduating summa cum laude and Phi Beta Kappa from Harvard in 2005 with a bachelor’s degree in chemistry, Liu carried out his PhD at the Scripps Research Institute with Prof. Peter Schultz and his postdoc at UC Berkeley as a Miller Fellow with Prof. Adam Arkin. His group engineers specialized genetic systems that continuously and rapidly mutate user-selected genes in vivo, with applications in directed evolution, protein engineering, evolutionary biology, cell biology, and development.

Agenda Sessions

  • OrthoRep-driven Antibody Evolution

    2:15pm